Yi-Li Liu

Yi-Li Liu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Acta Biomaterialia
Verified
Journal Article
Closed access
DTDi Tie
Di Tie
Renguo GuanRenguo Guan
Renguo Guan
HLHuinan Liu
Huinan Liu
ACAaron Cipriano
Aaron Cipriano
YLYi-Li Liu
Yi-Li Liu
Norbert HortNorbert Hort
Norbert Hort

13 June 2022 in Research Square
Verified
Preprint
Open access
PDF file
YWYuanhao Wang
Yuanhao Wang
NLNing Li
Ning Li
XZXingwang Zhu
Xingwang Zhu
YWYixiang Wang
Yixiang Wang
YLYi-Li Liu
Yi-Li Liu
BackgroundThe urinary bladder's mixed neuroendocrine-non-neuroendocrine neoplasm is a sporadic malignant tumor. Because of its rare incidence rate, the optimal treatment options for patients with mixed neuroendocrine-non-neuroendocrine neoplasm of the urinary bladder remain unknown.Case presentationA 61-year-old man was diagnosed with bladder cancer by cystoscopy due to painless gross hematuria. The patient then underwent transurethral resection of the bladder tumor. The postoperative pathological and immunohistochemical examination confirmed a mixed neuroendocrine-non-neuroendocrine neoplasm of the urinary bladder with small cell carcinoma and urothelial. The patient finally received radical cystectomy and cisplatin plus etoposide chemotherapy. There was no recurrence and metastasis three months after the operation.ConclusionThis case is a rare and high-risk pathological type of bladder malignant tumor. After radical cystectomy and postoperative adjuvant treatment, there was no tumor recurrence and metastasis three months after the operation. Radical cystectomy is still the preferred treatment for high-risk bladder cancer without distant metastasis.